Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

Delayed Quote. Delayed  - 05/24 09:23:22 pm
120.76 USD   +1.11%
05/23 ZIMMER BIOMET : May 23, 2016 Zimmer Biomet Announces Quarterly Divid..
05/16 ZIMMER BIOMET : May 16, 2016 Zimmer Biomet Completes Acquisition of ..
04/29 ZIMMER BIOMET : Shares its Financial Results for the First Quarter o..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Biomet 3Q Loss Widens On Charges; Sales Grow 5%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/11/2012 | 04:51pm CEST

("Biomet 3Q Loss Widens On Charges; Sales Grow 5%," at 7:03 a.m. EDT, misstated the hip sales increase in the sixth paragraph. The correct version follows:)

Biomet Inc.'s fiscal third-quarter loss widened on merger-related costs as strong sales for sports medicine, extremities and trauma helped drive the orthopedic medical-device maker's top-line growth.

Though privately held, Biomet's results are closely watched because the company reports earlier than larger competitors--such as Zimmer Holdings Inc. (>> Zimmer Holdings, Inc.), Stryker Corp. (SYK) and Johnson & Johnson (>> Johnson & Johnson)--and could foreshadow industry trends.

Biomet has seen its losses widen in recent quarters, weighed down by charges related to its $11.4 billion buyout in 2007 by a private-equity consortium including affiliates from The Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts & Co. and TPG. Sales have also been weak as patients, worried about out-of-pocket costs or long absences from work to recover, opt to defer hip and knee-replacement procedures. Biomet has said it is unclear when demand will come back.

For the quarter ended Feb. 29, Biomet reported a loss of $16.5 million, compared with a loss of $11.6 million a year earlier. Excluding merger and other special items, adjusted earnings fell to $55.1 million from $63.8 million. Sales jumped 4.5% to $708.9 million.

Gross margin slipped to 69% from 69.3%.

The company, which distributes products in about 90 countries, said worldwide hip sales increased 6%, while worldwide knee sales grew 4%. Sales for sports medicine, extremities and trauma were up 16%, while the spine and bone healing segment saw a 5% drop.

U.S. sales grew 5% while Europe sales rose 2.1%. International sales, which include Canada, South America, Mexico and the Asia-Pacific region, jumped 7.2%.

Last week, Biomet made a binding offer to acquire the global trauma business of Johnson & Johnson's DePuy Orthopaedics Inc. for about $280 million in cash, a deal the company said would greatly expand its sports, extremities and trauma business. Biomet also recently agreed to pay $23 million in penalties to settle U.S. allegations that it bribed doctors in Brazil, China and other countries over a period of years.

--By Anne Pallivathuckal and Melodie Warner, Dow Jones Newswires; 212-416-2283; melodie.warner@dowjones.com

Stocks mentioned in the article : Zimmer Holdings, Inc., Johnson & Johnson
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on ZIMMER BIOMET HOLDINGS INC
05/23 ZIMMER BIOMET : May 23, 2016 Zimmer Biomet Announces Quarterly Dividend for Seco..
05/16 ZIMMER BIOMET : May 16, 2016 Zimmer Biomet Completes Acquisition of Cayenne Medi..
05/09 ZIMMER BIOMET HOLDINGS, INC. : Change in Directors or Principal Officers, Submis..
05/05 ZIMMER BIOMET : Reports First Quarter 2016 Financial Results
05/05 ZIMMER BIOMET : Enters into Definitive Agreement to Acquire Cayenne Medical
04/29 ZIMMER BIOMET : Shares its Financial Results for the First Quarter of 2016
04/28DJZimmer Biomet Raises Outlook as 1Q Results Top Views
04/28 ZIMMER BIOMET : Apr 28, 2016 Zimmer Biomet Holdings, Inc. Reports First Quarter ..
04/28 ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition, Fi..
04/28 ZIMMER BIOMET : beats Street 1Q forecasts
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials